These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 16613001)
1. [The clinicofunctional characterization of the phenotypes of severe uncontrollable bronchial asthma]. Kobiakova OS; Nikitina LIu; Ogorodova LM; Smetanenko TV; Petrovskiĭ FI; Deev IA Klin Med (Mosk); 2006; 84(2):24-7. PubMed ID: 16613001 [TBL] [Abstract][Full Text] [Related]
2. Inhaled corticosteroid therapy in asthma: a balancing act. Li JT Ann Allergy Asthma Immunol; 1999 Mar; 82(3):229-30. PubMed ID: 10094213 [No Abstract] [Full Text] [Related]
3. [How to make easier the treatment of asthma]. Ait-Khaled N Rev Mal Respir; 2006 Sep; 23(4 Pt 2):10S76-10S79. PubMed ID: 17127972 [No Abstract] [Full Text] [Related]
4. Asthma in primary care. Usta J; Mroueh S J Med Liban; 2001; 49(5):284-7. PubMed ID: 12243423 [TBL] [Abstract][Full Text] [Related]
5. Treatment of severe asthma. Franklin W N Engl J Med; 1974 Jun; 290(26):1469-72. PubMed ID: 4151609 [No Abstract] [Full Text] [Related]
6. Controlling asthma. Highlights of the 1999 Canadian Asthma Consensus Report. D'Urzo AD Can Fam Physician; 2000 Apr; 46():895-8, 902-4. PubMed ID: 10790822 [No Abstract] [Full Text] [Related]
7. [Official therapy guidelines for the family physician. Your time table in asthma]. Koczorek M MMW Fortschr Med; 2002 Feb; 144(8):6-10. PubMed ID: 11910831 [No Abstract] [Full Text] [Related]
8. [Factors responsible for the course and long-term outcomes of bronchial asthma: chemotherapy]. Makolkin VI; Ovcharenko SI; Sheianov MV Klin Med (Mosk); 1997; 75(7):59-65. PubMed ID: 9411060 [TBL] [Abstract][Full Text] [Related]
10. [Experience in the use of flixotide in the treatment of bronchial asthma]. Dmitriev IuK; Duganov VK Voen Med Zh; 2000 Jul; 321(7):44-6. PubMed ID: 12886536 [No Abstract] [Full Text] [Related]
11. Pharmacologic therapy for the treatment of asthma in children. Waikart L; Blaiss MS Minerva Pediatr; 2004 Oct; 56(5):457-67. PubMed ID: 15459571 [TBL] [Abstract][Full Text] [Related]
12. Sputum indoleamine-2, 3-dioxygenase activity is increased in asthmatic airways by using inhaled corticosteroids. Maneechotesuwan K; Supawita S; Kasetsinsombat K; Wongkajornsilp A; Barnes PJ J Allergy Clin Immunol; 2008 Jan; 121(1):43-50. PubMed ID: 18036645 [TBL] [Abstract][Full Text] [Related]
13. [Treatment of exacerbation of asthma: what are today's issues?]. Ploin D; Rousson A; Vitoux-Brot C; Nouyrigat V; Foucaud P; Lemaire JP; Chevallier B; Bergeron S; Martinot A; Chéron G; Floret D Arch Pediatr; 2005 Mar; 12(3):351-6. PubMed ID: 15734138 [TBL] [Abstract][Full Text] [Related]
14. A study to evaluate safety and efficacy of mepolizumab in patients with moderate persistent asthma. Flood-Page P; Swenson C; Faiferman I; Matthews J; Williams M; Brannick L; Robinson D; Wenzel S; Busse W; Hansel TT; Barnes NC; Am J Respir Crit Care Med; 2007 Dec; 176(11):1062-71. PubMed ID: 17872493 [TBL] [Abstract][Full Text] [Related]
15. The beneficial effects of Xolair (omalizumab) as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available treatment (GINA 2002 step IV)--the Israeli arm of the INNOVATE study. Sthoeger ZM; Eliraz A; Asher I; Berkman N; Elbirt D Isr Med Assoc J; 2007 Jun; 9(6):472-5. PubMed ID: 17642399 [TBL] [Abstract][Full Text] [Related]
16. Recent trends and directions in the rationalization of pharmacotherapy of bronchial asthma: probing for alternatives. Das BP; Sethi A Kathmandu Univ Med J (KUMJ); 2006; 4(3):368-78. PubMed ID: 18603937 [TBL] [Abstract][Full Text] [Related]